Back to Search
Start Over
Oral
- Source :
- Cancers. 14(19)
- Publication Year :
- 2022
-
Abstract
- This study aims to find a correlation betweenThe protocol was registered on ClinicalTrials.gov (ID: NCT04009161) and approved by the ethical committee of the 'Fondazione Policlinico Universitario Gemelli IRCCS' (22858/18). An oral swab was obtained before RT to assess the presence ofNo patient developed G4 OM, and only 36/152 patients (23.7%) developed G3 OM. Tumour site and lymphocytopenia were risk factors for severe OM (OR for tumour site: 1.29, 95% CI: 1-1.67
Details
- ISSN :
- 20726694
- Volume :
- 14
- Issue :
- 19
- Database :
- OpenAIRE
- Journal :
- Cancers
- Accession number :
- edsair.pmid..........816bb18201c3f1919b2f603e86e9f354